+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Non Invasive Prenatal Testing"

Non-invasive Prenatal Testing Market - Global Forecast 2026-2032 - Product Thumbnail Image

Non-invasive Prenatal Testing Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 181 Pages
  • Global
From
From
Non-invasive Prenatal Testing Market Report 2026 - Product Thumbnail Image

Non-invasive Prenatal Testing Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
2025 Diagnostics Research Review - Product Thumbnail Image

2025 Diagnostics Research Review

  • Report
  • April 2026
  • 277 Pages
  • Global
From
From
From
From
From
From
Prenatal Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Prenatal Diagnostics - Global Strategic Business Report

  • Report
  • May 2026
  • 484 Pages
  • Global
From
Prenatal DNA Sequencing Market Report 2026 - Product Thumbnail Image

Prenatal DNA Sequencing Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator

Non-invasive prenatal testing (NIPT) is a type of prenatal screening used to detect chromosomal abnormalities in a fetus. It is a safe and accurate method of testing that does not involve any risk to the mother or fetus. NIPT is typically used to detect Down syndrome, trisomy 18, and trisomy 13, as well as other chromosomal abnormalities. It is also used to determine the sex of the fetus. NIPT is becoming increasingly popular as an alternative to traditional invasive prenatal testing, such as amniocentesis and chorionic villus sampling. NIPT is offered by a variety of diagnostic companies, including Illumina, Natera, Ariosa Diagnostics, and Sequenom. These companies provide a range of services, from laboratory testing to genetic counseling. They also offer a variety of testing options, such as single-gene tests, whole-genome sequencing, and targeted sequencing. Show Less Read more